Telaglenastat Uses, Dosage, Side Effects and more
Telaglenastat is under investigation in clinical trial NCT02071862 (Study of the Glutaminase Inhibitor CB-839 in Solid Tumors).
Trade Name | Telaglenastat |
Generic | Telaglenastat |
Telaglenastat Other Names | Telaglenastat |
Type | |
Formula | C26H24F3N7O3S |
Weight | Average: 571.58 Monoisotopic: 571.161343324 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |